Treatments utilizing Clustered Regularly Interspace Short Palindromic Repeats (CRISPR), continue to rack up clinical success. The latest research on blood…
McAlinden Research PartnersJune 16, 2020
New research on CRISPR techniques that could provide treatments and improved diagnostics for several major viruses and other medical conditions…
McAlinden Research PartnersNovember 13, 2019
New developments in CRISPR gene editing technology have opened the door to potential cures for 89% of known disease-causing genetic…
McAlinden Research PartnersOctober 29, 2019
After some major hiccups last year, new breakthroughs suggest CRISPR is becoming a mainstay in healthcare. The technology is now…
McAlinden Research PartnersMay 28, 2019
Startups are experimenting with the gene-editing technology CRISPR to make lab-grown meat a commercially viable reality. Meanwhile, the first commercially…
McAlinden Research PartnersMarch 18, 2019
“CRISPR babies” have been on everyone’s lips since news broke last week that Chinese scientists claimed they had produced the…
McAlinden Research PartnersDecember 4, 2018
CRISPR stocks have gotten battered in the second half of the year, yet the precision gene-editing technology is proving to…
McAlinden Research PartnersOctober 25, 2018
While the US meat industry has lately been racked by trade war fallout, resulting in huge surpluses, domestic demand is…
McAlinden Research PartnersAugust 9, 2018
Market reaction to a report that cells edited with CRISPR technology can activate a cancer-causing gene has been severe for…
McAlinden Research PartnersJune 13, 2018
